Progress towards The Lancet Commission on Global Surgery's 2030 targets has been too slow and too patchy, particularly in low ...

New Jersey woman nearly dies after taking dangerous amount of popular supplement: ‘I was very, very, very scared’ - New Jersey resident Katie Mohan says her daily turmeric supplements gave her ‘impend ...

Global health leaders and advocates challenged attendees of IAS to support the work of the partnerships that are creating patient-focused innovations for HIV prevention and treatment.

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according to a press release .

New research from The University of Texas at Austin suggests that exercising more frequently—ideally every day—could improve ...

Menzies School of Health Research has led the largest-ever study of people living with a unique strain of chronic hepatitis B ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Hepatitis B is relatively frequent in the Bouaké military region, with a prevalence of 5.23%. It predominantly affects ...

The new study found that Midwestern states had the highest rates of obesity-linked cancer deaths, while the Northeast fared ...